Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Dyslipidemia”

915 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 915 results

Not applicableStudy completedNCT01483950
What this trial is testing

Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values

Who this might be right for
Hypercholesterolaemia
AstraZeneca 800
Post-approval studies (Phase 4)Study completedNCT00699023
What this trial is testing

Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes

Who this might be right for
Postprandial LipemiaType 2 Diabetes
Federico II University 13
Post-approval studies (Phase 4)Study completedNCT00644670
What this trial is testing

The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol

Who this might be right for
Dyslipidemias
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 232
Large-scale testing (Phase 3)Study completedNCT04074551
What this trial is testing

Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

Who this might be right for
HypertensionDyslipidemias
Hanmi Pharmaceutical Company Limited 145
Not applicableStudy completedNCT01206231
What this trial is testing

An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
AstraZeneca 330
Large-scale testing (Phase 3)Study completedNCT01370603
What this trial is testing

Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)

Who this might be right for
Hypercholesterolemia
Organon and Co 328
Large-scale testing (Phase 3)Study completedNCT00217061
What this trial is testing

Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes MellitusDyslipidemiaHypercholesterolemia+1 more
Mayo Clinic 98
Post-approval studies (Phase 4)Looking for participantsNCT06750783
What this trial is testing

The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes

Who this might be right for
Prediabetic State (IGT)
Beijing Tsinghua Chang Gung Hospital 398
Large-scale testing (Phase 3)Study completedNCT04714151
What this trial is testing

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Who this might be right for
Dyslipidemias
Kowa Company, Ltd. 356
Post-approval studies (Phase 4)Study completedNCT03784703
What this trial is testing

Type 2 Diabetic Patients Maintained on Statin Therapy

Who this might be right for
Dyslipidemia Associated With Type II Diabetes Mellitus
Damanhour University 160
Early research (Phase 1)Study completedNCT05398029
What this trial is testing

VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaAtherosclerotic Cardiovascular DiseaseHypercholesterolemia
Verve Therapeutics, Inc. 13
Not applicableLooking for participantsNCT07238556
What this trial is testing

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

Who this might be right for
HypertensionDyslipidemiaDiabetes Mellitus+2 more
University of Connecticut 72
Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Large-scale testing (Phase 3)Study completedNCT00309777
What this trial is testing

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

Who this might be right for
HypercholesterolemiaDyslipidemia
Kowa Research Europe 857
Large-scale testing (Phase 3)Study completedNCT00254475
What this trial is testing

Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

Who this might be right for
Essential HypertensionHypercholesterolemia
Novartis 871
Not applicableStudy completedNCT04148001
What this trial is testing

Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
REGENXBIO Inc. 4
Testing effectiveness (Phase 2)Study completedNCT04079530
What this trial is testing

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Who this might be right for
Dyslipidemias
Kowa Company, Ltd. 60
Not applicableStudy completedNCT00999453
What this trial is testing

The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients

Who this might be right for
Hypercholesterolemia
Clinical Research Center for End Stage Renal Disease, Korea 43
Not applicableStudy completedNCT06293261
What this trial is testing

Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

Who this might be right for
HypertensionHypercholesterolemia
Yuhan Corporation 5,047
Testing effectiveness (Phase 2)Study completedNCT00160745
What this trial is testing

Rosuvastatin and Renal Endothelial Function

Who this might be right for
Hypercholesterolemia
University of Erlangen-Nürnberg Medical School 46
Load More Results